2026-04-13T06:53:32Zhttps://recercat.cat/oai/request
oai:recercat.cat:2445/2025342025-12-05T12:04:29Zcom_2072_1057col_2072_478916col_2072_478917
RECERCAT author Ronda, Mar author Llop Talaverón, Josep Manuel author Fuset, Maripaz author Leiva, Elisabet author Shaw, Evelyn author Gumucio Sanguino, Victor Daniel author Diez, Yolanda author Colom, Helena author Rigo Bonnin, Raúl author Puig Asensio, Mireia author Carratalà, Jordi author Padullés Zamora, Ariadna 2023-10-06T17:15:04Z2023-10-06T17:15:04Z2023-06-252023-08-16T15:05:12Z Voriconazole, an antifungal agent, displays high intra- and inter-individual variability. The predictive pharmacokinetic (PK) index requires a minimum plasma concentration (C-min) in patient serum of between 1-5.5 mg/L. It is common to encounter fungal infections in patients undergoing extracorporeal membrane oxygenation (ECMO) support, and data regarding voriconazole PK changes during ECMO are scarce. Our study compared voriconazole PKs in patients with and without ECMO support in a retrospective cohort of critically-ill patients. Fifteen patients with 26 voriconazole C-min determinations in the non-ECMO group and nine patients with 27 voriconazole C-min determinations in the ECMO group were recruited. The ECMO group had lower C-min (0.38 & PLUSMN; 2.98 vs. 3.62 & PLUSMN; 3.88, p < 0.001) and higher infratherapeutic C-min values (16 vs. 1, p < 0.001) than the non-ECMO group. Multivariate analysis identified ECMO support (-0.668, CI95 -0.978--0.358) and plasma albumin levels (-0.023, CI95 -0.046--0.001) as risk factors for low C-min values. When comparing pre- and post-therapeutic drug optimisation samples from the ECMO group, the dose required to achieve therapeutic C-min was 6.44 mg/kg twice a day. Therapeutic drug optimisation is essential to improve target attainment. cc by (c) Ronda, Mar et al., 2023 http://creativecommons.org/licenses/by/3.0/es/ info:eu-repo/semantics/openAccess Farmacocinètica Medicaments antifúngics Pharmacokinetics Antifungal agents Voriconazole Pharmacokinetics in Critically Ill Patients and Extracorporeal Membrane Oxygenation Support: A Retrospective Comparative Case-Control Study info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion